PRALYBRI CARBETOCIN
Dead / Abandoned — Abandoned — no statement of use filed (as of 14 Oct 2025)
What this means for you
This application is over — abandoned 14 Oct 2025. The name may be available, but check before relying on it — rights can also come from actual use, not only from the register.
Record
- Serial number
- 97107395
- Mark type
- Design + words
- Filed
- 03 Nov 2021
- Published for opposition
- 15 Feb 2022
- Abandoned
- 14 Oct 2025
- Attorney of record
- Carissa L. Weiss
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical products and preparations made in significant part of carbetocin for the treatment of Prader-Willi syndrome (PWS) and related disorders; pharmaceutical products and preparations made in significant part of carbetocin for the treatment of neurodevelopmental and metabolic disorders
Owner
- Levo Therapeutics, Inc., Skokie, IL, US
- Levo Therapeutics, Inc., Skokie, IL, US
Prosecution history
- 14 Oct 2025 — ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
- 14 Oct 2025 — ABANDONMENT - NO USE STATEMENT FILED
- 06 Oct 2024 — SOU EXTENSION 5 GRANTED
- 06 Oct 2024 — SOU EXTENSION 5 FILED
- 06 Oct 2024 — SOU TEAS EXTENSION RECEIVED
- 19 Mar 2024 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 18 Mar 2024 — SOU EXTENSION 4 GRANTED
- 18 Mar 2024 — SOU EXTENSION 4 FILED
- 18 Mar 2024 — SOU TEAS EXTENSION RECEIVED
- 22 Sept 2023 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 20 Sept 2023 — SOU EXTENSION 3 GRANTED
- 20 Sept 2023 — SOU EXTENSION 3 FILED
- 20 Sept 2023 — SOU TEAS EXTENSION RECEIVED
- 21 Mar 2023 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 17 Mar 2023 — SOU EXTENSION 2 GRANTED